April 3, 2019
Contaminated Umbilical Cord Blood

The Danger of Using Donor-derived Materials Without Good Quality Control: the Liveyon Debacle – Part Four

Over the past three posts (Part One, Part Two and Part Three) I have cited sections of 21 CFR 1271 as they relate to the manufacturing of HCT/Ps, such as cord blood-derived products produced by Genetech and sold by Liveyon that resulted in 15 patients (so far) suffering often severe adverse events due to having...
Read More